Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 4315-4322

  Balaiya, Sankarathi ^a   Ferguson, Lee R ^a   Chalam, Kakarla V ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; SIRTINOL; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN; NEUROPROTECTIVE AGENT; SIRTUIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HYPOXIA; IMMUNOBLOTTING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; ANOXIA; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CELL HYPOXIA; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; METABOLISM; OPTIC NEURITIS; PATHOLOGY;

ANOXIA; APOPTOSIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; HUMANS; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; OPTIC NEURITIS; RETINAL GANGLION CELLS; SIRTUINS;

EID: 84866285569     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-9259     Document Type: Article

References (46)

1. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18:39-57.
2. Wax MB, Tezel G. Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol. 2002;26:45-55.
3. Osborne NN, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999;43:S102-S128.
4. Chen Y, Yamada H, Mao W, et al. Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of betaadrenergic antagonists. Brain Res. 2007;1148:28-37.
5. Ota H, Tokunaga E, Chang K, et al. Sirt1 inhibitor, sirtinol induces senescence-like growth arrest with attenuated Ras- MAPK signaling in human cancer cells. Oncogene. 2006;25: 176-185.
6. Saunders LR, Verdin E. Stress response and aging. Science. 2009;323:1021-1022.
7. Jaliffa C, Ameqrane I, Dansault A, et al. Sirt1 involvement in rd10 mouse retinal degeneration. Invest Ophthalmol Vis Sci. 2009;50:3562-3572.
8. Tang BL. Sirt1's complex roles in neuroprotection. Cell Mol Neurobiol. 2009;29:1093-1103.
9. Quivy V, Van Lint C. Regulation at multiple levels of NF-jBmediated transactivation by protein acetylation. Biochem Pharmacol. 2004;68:1221-1229.
10. Young DA, Lakey RL, Pennington CJ, et al. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther. 2005;7:R503-R512.
11. Nasu Y, Nishida K, Miyazawa S, et al. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibodyinduced arthritis mouse model. Osteoarthritis Cartilage. 2008;16:723-732.
12. Dioum EM, Chen R, Alexander MS, et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stressresponsive deacetylase sirtuin 1. Science. 2009;324:1289-1293.
13. Shindler KS, Ventura E, Rex TS, Elliott P, Rostami A. SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci. 2007;48:3602-3609.
14. Frassetto LJ, Schlieve CR, Lieven CJ, et al. Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest Ophthalmol Vis Sci. 2006;47:427-438.
15. Yang C, Lafleur J, Mwaikambo BR, et al. The role of lysophosphatidic acid receptor (LPA1) in the oxygen-induced retinal ganglion cell degeneration. Invest Ophthalmol Vis Sci. 2009;50:1290-1298.
16. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia inducible factor-a and von Hippel-Lindau protein by direct binding to hypoxia inducible factor-a. J Biol Chem. 2003;278:15911-15916.
17. 2 -induced HIF-1a expression correlates with proliferation and apoptosis in MKN-1 cells: a possible role for the PI3K/Akt pathway. Int J Oncol. 2006;29:549-555.
18. Tulsawani R, Kelly LS, Fatma N, et al. Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage. BMC Neurosci. 2010;11:125.
19. Lim JH, Lee YM, Chun YS, et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010;38:864-878.
20. Zhang Z, Lowry SF, Guarente L, et al. Roles of SIRT1 in the acute and restorative phases following induction of inflammation. J Biol Chem. 2010;285:41391-41401.
21. Zhong L, D'Urso A, Toiber D, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell. 2010; 140:280-293.
22. Roduit R, Schorderet DF. MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE-19 cells. Apoptosis. 2008;13:343-353.
23. Estus S, Zaks WJ, Freeman RS, et al. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol. 1994;127: 1717-1727.
24. Virdee K, Bannister AJ, Hunt SP, Tolkovsky AM. Comparison between the timing of JNK activation, c-Jun phosphorylation, and onset of death commitment in sympathetic neurones. J Neurochem. 1997;69:550-561.
25. Yuan J, Yankner BA. 2000. Apoptosis in the nervous system. Nature. 2000;407:802-809.
26. Levkovitch-Verbin H, Quigley HA, Martin KRG, et al. The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma. Exp Eye Res. 2005;80:663-670.
27. Robinson GA. Immediate early gene expression in axotomized and regenerating retinal ganglion cells of the adult rat. Brain Res Mol Brain Res. 1994;24:43-54.
28. Kreutz MR, Bien A, Vorwerk CK, et al. Co-expression of c-Jun and ATF-2 characterizes the surviving retinal ganglion cells which maintain axonal connections after partial optic nerve injury. Brain Res Mol Brain Res. 1999;69:232-241.
29. Mesner PW, Epting CL, Hegarty JL, Green SHA. A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J Neurosci. 1995; 15:7357-7366.
30. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9:726-735.
31. Gao Z, Zhang J, Kheterpal N, et al. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J Biol Chem. 2011;286:22227-22234.
32. Seo JS, Moon MH, Jeong JK, et al. SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiol Aging. 2012;33:1110-1120.
33. Hou J, Chong ZZ, Shang YC, et al. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res. 2010;7:95-112.
34. Takayama K, Ishida K, Matsushita T, et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum. 2009;60: 2731-2740.
35. Anekonda TS, Adamus G. Resveratrol prevents antibodyinduced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes. 2008;1:122.
36. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A. 2000;97:10242-10247.
37. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci. 1999;19: 5731-5740.
38. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci. 2000; 12:4243-4254.
39. Schwarz Q, Gu C, Fujisawa H, et al. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev. 2004;18:2822-2834.
40. Storkebaum E, Lambrechts D, Dewerchin M, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005;8:85-92.
41. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001;28:131-138.
42. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34:383-394.
43. Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007;171:53-67.
44. Zhang Q, Wang SY, Fleuriel C, et al. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci U S A. 2007; 104:829-833.
45. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460:587-591.
46. He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010; 120:1056-1068.